Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Kiora Pharmaceuticals Inc. diskutieren

Kiora Pharmaceuticals Inc.

WKN: A3DZ7F / Symbol: KPRX / Name: Kiora Pharmaceuticals / Aktie / Micro Cap /

0,45 €
-0,33 %

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Ratings data for KPRX provided by MarketBeat

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Ratings data for KPRX provided by MarketBeat

Einschätzung Buy
Rendite (%) -18,75 %
Kursziel 3,27
Veränderung
Endet am 13.11.24

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.50 price target on the stock.
Ratings data for KPRX provided by MarketBeat

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Ratings data for KPRX provided by MarketBeat